Ryan J. Watts insider trades: Denali Therapeutics (DNLI) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ryan reports to the SEC
Open-market buys and sales
51 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | DNLI | ↓ Sell | 35,198 | $16.50 | $581K | Direct | Jan 8, 2026 (2d) |
| Jul 9, 2025 | DNLI | ↓ Sell | 495,282 | $15.00 | $7.4M | Direct | Jul 11, 2025 (2d) |
| Jan 7, 2025 | DNLI | ↓ Sell | 36,916 | $20.34 | $751K | Direct | Jan 8, 2025 (1d) |
| Oct 18, 2024 | DNLI | ↓ Sell | 40,000 | $27.69 | $1.1M | Direct | Oct 22, 2024 (4d) |
| Aug 20, 2024 | DNLI | ↓ Sell | 2,260 | $23.79 | $54K | Direct | Aug 22, 2024 (2d) |
| Feb 13, 2024 | DNLI | ↓ Sell | 9,589 | $17.29 | $166K | Direct | Feb 15, 2024 (2d) |
| Jan 9, 2024 | DNLI | ↓ Sell | 7,818 | $19.78 | $155K | Indirect | Jan 11, 2024 (2d) |
| Jan 5, 2024 | DNLI | ↓ Sell | 17,483 | $19.43 | $340K | Indirect | Jan 9, 2024 (4d) |
| Aug 21, 2023 | DNLI | ↓ Sell | 2,309 | $22.59 | $52K | Indirect | Aug 23, 2023 (2d) |
| Aug 10, 2023 | DNLI | ↓ Sell | 2,526 | $25.03 | $63K | Indirect | Aug 14, 2023 (4d) |
| Jun 16, 2023 | DNLI | ↓ Sell | 50,000 | $31.40 | $1.6M | Indirect | Jun 20, 2023 (4d) |
| Apr 21, 2023 | DNLI | ↓ Sell | 25,000 | $25.15 | $629K | Indirect | Apr 24, 2023 (3d) |
| Feb 13, 2023 | DNLI | ↓ Sell | 33,815 | $30.08 | $1.0M | Indirect | Feb 15, 2023 (2d) |
| Feb 10, 2023 | DNLI | ↓ Sell | 28,433 | $29.28 | $833K | Indirect | Feb 13, 2023 (3d) |
| Jan 5, 2023 | DNLI | ↓ Sell | 4,800 | $28.44 | $137K | Indirect | Jan 9, 2023 (4d) |
| Jan 4, 2023 | DNLI | ↓ Sell | 5,029 | $28.73 | $144K | Indirect | Jan 5, 2023 (1d) |
| Aug 19, 2022 | DNLI | ↓ Sell | 2,404 | $33.22 | $80K | Indirect | Aug 23, 2022 (4d) |
| Feb 11, 2022 | DNLI | ↓ Sell | 9,491 | $34.72 | $330K | Indirect | Feb 15, 2022 (4d) |
| Feb 9, 2022 | DNLI | ↓ Sell | 2,719 | $37.55 | $102K | Indirect | Feb 11, 2022 (2d) |
| Jan 5, 2022 | DNLI | ↓ Sell | 5,007 | $44.78 | $224K | Indirect | Jan 7, 2022 (2d) |
| Dec 1, 2021 | DNLI | ↓ Sell | 18,333 | $44.92 | $824K | Indirect | Dec 3, 2021 (2d) |
| Nov 1, 2021 | DNLI | ↓ Sell | 18,333 | $49.76 | $912K | Indirect | Nov 3, 2021 (2d) |
| Oct 1, 2021 | DNLI | ↓ Sell | 18,333 | $50.38 | $924K | Indirect | Oct 5, 2021 (4d) |
| Sep 1, 2021 | DNLI | ↓ Sell | 18,333 | $54.66 | $1.0M | Indirect | Sep 3, 2021 (2d) |
| Aug 19, 2021 | DNLI | ↓ Sell | 2,376 | $49.57 | $118K | Indirect | Aug 23, 2021 (4d) |
| Aug 2, 2021 | DNLI | ↓ Sell | 18,333 | $51.41 | $942K | Indirect | Aug 4, 2021 (2d) |
| Jul 1, 2021 | DNLI | ↓ Sell | 18,333 | $77.25 | $1.4M | Indirect | Jul 6, 2021 (5d) |
| Jun 1, 2021 | DNLI | ↓ Sell | 18,333 | $61.40 | $1.1M | Indirect | Jun 3, 2021 (2d) |
| May 3, 2021 | DNLI | ↓ Sell | 18,333 | $58.64 | $1.1M | Indirect | May 5, 2021 (2d) |
| Apr 1, 2021 | DNLI | ↓ Sell | 18,334 | $56.60 | $1.0M | Indirect | Apr 5, 2021 (4d) |
| Mar 1, 2021 | DNLI | ↓ Sell | 18,334 | $66.35 | $1.2M | Indirect | Mar 3, 2021 (2d) |
| Feb 11, 2021 | DNLI | ↓ Sell | 9,473 | $70.30 | $666K | Indirect | Feb 16, 2021 (5d) |
| Feb 9, 2021 | DNLI | ↓ Sell | 5,112 | $73.79 | $377K | Indirect | Feb 10, 2021 (1d) |
| Feb 1, 2021 | DNLI | ↓ Sell | 18,334 | $68.44 | $1.3M | Indirect | Feb 2, 2021 (1d) |
| Jan 4, 2021 | DNLI | ↓ Sell | 88,334 | $74.96 | $6.6M | Indirect | Jan 6, 2021 (2d) |
| Mar 30, 2020 | DNLI | ↓ Sell | 4,807 | $19.48 | $94K | Direct | Apr 1, 2020 (2d) |
| Dec 4, 2019 | DNLI | ↓ Sell | 21,268 | $18.00 | $383K | Indirect | Dec 5, 2019 (1d) |
| Nov 25, 2019 | DNLI | ↓ Sell | 43,485 | $18.02 | $784K | Indirect | Nov 26, 2019 (1d) |
| Sep 5, 2019 | DNLI | ↓ Sell | 8,581 | $18.05 | $155K | Indirect | Sep 5, 2019 (0d) |
| Jul 1, 2019 | DNLI | ↓ Sell | 18,333 | $20.76 | $381K | Indirect | Jul 3, 2019 (2d) |
| Jun 3, 2019 | DNLI | ↓ Sell | 18,333 | $19.07 | $350K | Indirect | Jun 5, 2019 (2d) |
| May 3, 2019 | DNLI | ↓ Sell | 18,334 | $24.20 | $444K | Indirect | May 3, 2019 (0d) |
| Apr 3, 2019 | DNLI | ↓ Sell | 18,333 | $25.03 | $459K | Indirect | Apr 3, 2019 (0d) |
| Mar 5, 2019 | DNLI | ↓ Sell | 18,333 | $22.18 | $407K | Indirect | Mar 5, 2019 (0d) |
| Feb 5, 2019 | DNLI | ↓ Sell | 18,334 | $18.72 | $343K | Indirect | Feb 5, 2019 (0d) |
| Jan 4, 2019 | DNLI | ↓ Sell | 18,333 | $19.43 | $356K | Indirect | Jan 4, 2019 (0d) |
| Dec 3, 2018 | DNLI | ↓ Sell | 18,333 | $18.43 | $338K | Indirect | Dec 6, 2018 (3d) |
| Nov 15, 2018 | DNLI | ↓ Sell | 18,334 | $18.09 | $332K | Indirect | Nov 15, 2018 (0d) |
| Oct 1, 2018 | DNLI | ↓ Sell | 18,333 | $21.72 | $398K | Indirect | Oct 3, 2018 (2d) |
| Sep 4, 2018 | DNLI | ↓ Sell | 18,333 | $19.06 | $349K | Indirect | Sep 6, 2018 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other DNLI insiders
Open-market trades in the last 12 months
About Ryan J. Watts's insider trades
Ryan J. Watts is President and CEO at Denali Therapeutics (DNLI). Since Aug 29, 2018, Ryan has reported no open-market purchases and 51 sales worth $41.2M on SEC Form 4. In the last 12 months: 1 sale ($581K).
Their filings also include grants and awards (10 filings), option exercises (9 filings), gifts (7 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DNLI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.